Please do not leave this page until complete. This can take a few moments.
The company that makes and sells OxyContin has reportedly agreed to a settlement with 22 state attorneys general and thousands of municipalities, but not Massachusetts Attorney General Maura Healey, who is pledging to continue her fight against Purdue Pharma.
The Washington Post reported Wednesday that Purdue Pharma is in agreement "with 22 state attorneys general and more than 2,000 cities and counties that sued the company and accused it of fueling the opioid crisis."
The Associated Press reported the settlement "is the same as one publicly reported several weeks ago" — between $7 billion and $9 billion from Purdue Pharma, including some in the form of future proceeds from the sale of OxyContin after the company restructures through Chapter 11 bankruptcy, and $3 billion from the personal fortune of the Sackler family, which owns Purdue.
Healey, who had been opposed to that reported settlement offer out of concern that the Sacklers would not contribute enough of their own fortune, is not one of the attorneys general who signed onto the settlement, her office said.
"The families who were hurt by Purdue and the Sacklers have spoken loud and clear that this case demands real accountability, and I will continue to fight for that," Healey said in a statement Wednesday. "It's critical that all the facts come out about what this company and its executives and directors did, that they apologize for the harm they caused, and that no one profits from breaking the law. These families deserve justice."
Healey was not made available to the News Service on Wednesday, but her office said the attorney general will continue to pursue her case as filed in Massachusetts Superior Court and will go after both Purdue and the Sackler family in bankruptcy court if or when the company pursues that avenue.
Over the weekend, the Associated Press and National Public Radio reported that the Sackler family rejected demands that they forfeit $4.5 billion of their own money as part of the settlement. Previous reports had pegged the amount coming from the Sacklers' pockets in the proposed settlement at $3 billion over seven years and another $1.5 billion from the sale of another family-owned company.
Healey has declined to talk about the high-stakes settlement talks with the painkiller maker, but said in a statement last week that her office's suit against Purdue and the Sacklers is about "exposing the facts, making them pay for the harm they caused, and shutting them down for good."
Previous reporting on the potential settlement said that the Sackler family would relinquish ownership and control of Purdue Pharma, and the Connecticut-based drug manufacturer would then file for Chapter 11 bankruptcy and restructure itself as a "public beneficiary trust." Future profits from the company would flow to the plaintiffs. Purdue would also provide the addiction treatment drugs that it has under development to the public at no cost.
In June 2018, Healey filed the first state lawsuit against individual members of the Sackler family, as well as Purdue Pharma, alleging that they "engaged in a deadly, deceptive scheme to sell opioids in Massachusetts" and profited from the drug epidemic they helped create.
Healey's complaint alleges that Purdue "created the epidemic and profited from it through a web of illegal deceit" by misleading doctors and patients to get more people using their drugs, at "higher and more dangerous doses" and for longer periods of time, as well as by deploying falsehoods to keep patients away from "safer alternatives."
A total of 671 Massachusetts residents who filled prescriptions for Purdue opioids since 2009 later died of an opioid overdose, according to the suit. According to Healey's office, Purdue sent sales representatives to Massachusetts doctors offices, clinics and hospitals more than 150,000 times since 2008.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments